Delivery Order SPE2DB20D1004-SPE2DB25FNHAY
Award Date
5/15/25
Potential Completion Date
5/16/25
Potential Value
$1.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Imatinib Mesylate 400 mg tablets, a medication used to treat certain types of cancer. The contract has a ceiling value of $1,032.97 and a completion date of February 14, 2025. This contract is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,568,139,158 units of Imatinib Mesylate 400 mg tablets in 30-count packages, with a ceiling value of $1,179.42. The contract is a firm-fixed-price, non-set-aside contract type with a performance period through May 6, 2025. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $2,242.05 Firm Fixed Price Delivery Order is for the supply of 4,558,265,473 units of Imatinib Mesylate 100 mg tablets. The contract has an ultimate completion date of August 30, 2022. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This is a delivery order contract awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of 4559491180 - Imatinib Mesylate 400 mg tablets in 30-count packages. The contract has a ceiling value of $2,099.53 and is a firm-fixed-price delivery order. The award date was January 3, 2023, with an ultimate completion date of January 4, 2023. This delivery order is issued under a larger Indefinite...
This federal contract award, with ID SPE2DX15D1053|SPE2DX24F6JDQ, is for the delivery of 4,563,971,891 units of Imatinib Mesylate 400 mg tablets in packages of 30. The contract has a firm fixed price of $1,416.39 and an ultimate completion date of March 15, 2024. The award was made on March 14, 2024 to the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. doing business as Amerisourcebergen. The contract was awarded by the Defense Logistics Agency...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order valued at $1,369.66 with a completion date of November 18, 2024. The contract provides the Defense Logistics Agency (DLA) with 4566447009 - IMATINIB MESYLATE 400 MG TAB 30S, a pharmaceutical product. The contract is a Firm Fixed Price arrangement with no set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,141.83 firm fixed-price delivery order is for the supply of 4,559,069,294 units of Imatinib Mesylate 400mg tablets. The award has an ultimate completion date of November 14, 2022 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite...
The Defense Logistics Agency awarded a $62,130 delivery order to Amerisourcebergen Drug Corporation for Imatinib Mesylate 100mg tablets. Under this firm fixed price contract, Amerisourcebergen will provide 90 tablets of the generic cancer drug to an address in Conshohocken, Pennsylvania by June 28, 2023. As a major supplier of pharmaceuticals to the Department of Defense, Amerisourcebergen frequently receives delivery orders under the DLA's Prime Vendor program to support the medical readiness...
Amerisourcebergen Drug Corp has received a firm fixed price delivery order valued at one thousand nine hundred fourteen dollars and twenty-five cents ($1,914.25) from the Defense Logistics Agency (DLA) Troop Support Medical program. As the prime contractor, Amerisourcebergen will supply one hundred (100) tablets of Imatinib Mesylate at one hundred (100) milligrams per tablet to the DLA, with performance taking place at its headquarters in Conshohocken, Pennsylvania. The delivery order was...
Amerisourcebergen Drug Corp has received a firm fixed price delivery order valued at two thousand two hundred three dollars and two cents ($2,203.02) from the Defense Logistics Agency (DLA) Troop Support Medical. The order is for thirty (30) tablets of Imatinib Mesylate 400mg to be delivered by November 13, 2023 from Amerisourcebergen's headquarters in Conshohocken, Pennsylvania. No set aside designation was applied to this award made against an indefinite delivery contract held by...